Advanced search
Publication Cover
Vascular Health and Risk Management Volume 9, 2013 - Issue
Submit an article Journal homepage
222
Views
64
CrossRef citations to date
0
Altmetric
Original Research

Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study

Elliot Offman1 Clinical Pharmacology Sciences, Celerion, Montreal, QC, CanadaCorrespondence[email protected]
,
Ted Marenco1 Clinical Pharmacology Sciences, Celerion, Montreal, QC, Canada
,
Sandy Ferber2 Array Biostatistics LLC, Evanston, IL, Usa
,
Judith Johnson3 Omthera Pharmaceuticals Inc, Princeton, NJ, USA
,
Douglas Kling3 Omthera Pharmaceuticals Inc, Princeton, NJ, USA
,
Danielle Curcio3 Omthera Pharmaceuticals Inc, Princeton, NJ, USA
&
Michael Davidson3 Omthera Pharmaceuticals Inc, Princeton, NJ, USA
 show all
Pages 563-573 | Published online: 01 Oct 2013

Citations (64)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

David Rhainds, Mathieu R. Brodeur & Jean-Claude Tardif. (2019) Investigational drugs in development for hypertriglyceridemia: a coming-of-age story. Expert Opinion on Investigational Drugs 28:12, pages 1059-1079.
Read now
Lane B Benes, Nikhil S Bassi & Michael H Davidson. (2016) Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia. Vascular Health and Risk Management 12, pages 481-490.
Read now
Angela Pirillo & Alberico Luigi Catapano. (2015) Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3. Drug Design, Development and Therapy 9, pages 2129-2137.
Read now
Eli M Roth. (2015) ω-3 carboxylic acids for hypertriglyceridemia. Expert Opinion on Pharmacotherapy 16:1, pages 123-133.
Read now
Howard S. Weintraub. (2014) Overview of Prescription Omega-3 Fatty Acid Products for Hypertriglyceridemia. Postgraduate Medicine 126:7, pages 7-18.
Read now
Michael H Davidson, Alyssa K Phillips, Douglas Kling & Kevin C Maki. (2014) Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia. Expert Review of Cardiovascular Therapy 12:9, pages 1045-1054.
Read now
Kevin C Maki, Sylvia P Poulos, Alyssa K Phillips & Andrea L Lawless. (2014) Prescription omega-3 carboxylic acids for the treatment of severe hypertriglyceridemia. Clinical Lipidology 9:4, pages 399-406.
Read now
Terry A Jacobson. (2014) Perspectives on a new prescription omega-3 fatty acid, icosapent ethyl, for hypertriglyceridemia. Clinical Lipidology 9:2, pages 149-161.
Read now

Articles from other publishers (56)

Fei Yuan, Hui Li, Mengjie Yang, Weili Chen, Hanjing Chen, Hongrong Xu, Jing Li, Lei Sheng, Chao Liu, Ye Li, Huan Li & Xuening Li. (2022) Pharmacokinetics of Icosapent Ethyl: An Open‐Label, Multiple Oral Dose, Parallel Design Study in Healthy Chinese Subjects. Clinical Pharmacology in Drug Development 12:1, pages 6-13.
Crossref
Mohsen Montazer, Soraiya Ebrahimpour-Koujan, Pamela J Surkan & Leila Azadbakht. (2022) Effects of Fish-Oil Consumption on Psychological Function Outcomes in Psychosis: A Systematic Review and Dose–Response Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition 13:6, pages 2149-2164.
Crossref
Anna Kiełbasa, Bogusław Buszewski & Renata Gadzała-Kopciuch. (2022) A novel non-derivatization HPLC/UV method for the determination of some n-3 free fatty acids in breast milk matrix. Microchemical Journal 181, pages 107789.
Crossref
Mariko Hayashida, Yuri Ishii, Tomoki Adachi, Rie Imai, Nobuo Uotsu & Kei Yui. (2022) Pharmacokinetics of a Single Intake of a Self-Emulsifying Drug Delivery System Containing the Triglyceride Form of DHA: A Randomized, Double-Blinded, Crossover Study. Current Developments in Nutrition 6:9, pages nzac122.
Crossref
Kevin C. Maki, Harold E. Bays, Christie M. Ballantyne, James A. Underberg, John J. P. Kastelein, Judith B. Johnson, James J. Ferguson, Harold Bays, Allison Blomer, Kathleen Kelley, Alpa Patel, John K Scott, Ronald Z Surowitz, Philip D Toth & Rupal Trivedi. (2022) A Head‐to‐Head Comparison of a Free Fatty Acid Formulation of Omega‐3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE‐IT Study. Journal of the American Heart Association 11:6.
Crossref
Laura Bordoni, Irene Petracci, Fanrui Zhao, Weihong Min, Elisa Pierella, Taís Silveira Assmann, J Alfredo Martinez & Rosita Gabbianelli. (2021) Nutrigenomics of Dietary Lipids. Antioxidants 10:7, pages 994.
Crossref
Laurie Chevalier, Annick Vachon & Mélanie Plourde. (2021) Pharmacokinetics of Supplemental Omega-3 Fatty Acids Esterified in Monoglycerides, Ethyl Esters, or Triglycerides in Adults in a Randomized Crossover Trial. The Journal of Nutrition 151:5, pages 1111-1118.
Crossref
Laurie Chevalier & Mélanie Plourde. (2020) Comparison of pharmacokinetics of omega-3 fatty acid supplements in monoacylglycerol or ethyl ester in humans: a randomized controlled trial. European Journal of Clinical Nutrition 75:4, pages 680-688.
Crossref
Richard L. Dunbar, Daniel Gaudet, Michael Davidson, Martin Rensfeldt, Hong Yang, Catarina Nilsson, Mats Kvarnström & Jan Oscarsson. (2020) Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study. Lipids in Health and Disease 19:1.
Crossref
Shan Jing, Zhenxian Zhang, Xiaowen Chen, Rui Miao, Catarina Nilsson & Yang Lin. (2020) Pharmacokinetics of Single and Multiple Doses of Omega‐3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open‐Label Study. Clinical Pharmacology in Drug Development 9:8, pages 985-994.
Crossref
Bofeng Wei & Shaoyan Wang. (2020) Separation of eicosapentaenoic acid and docosahexaenoic acid by three-zone simulated moving bed chromatography. Journal of Chromatography A 1625, pages 461326.
Crossref
Koutaro Yokote, Kiyoshi Niwa, Tomomi Hakoda, Fumiki Oh, Yoshitaka Kajimoto, Toshiki Fukui, Hyosung KimYoshinori NodaTorbjörn Lundström & Toshitaka Yajima. (2020) Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia　― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―. Circulation Journal 84:6, pages 994-1003.
Crossref
Alexis Ceecee Zhang, Sumeer Singh, Jennifer P. Craig & Laura E. Downie. (2020) Omega-3 Fatty Acids and Eye Health: Opinions and Self-Reported Practice Behaviors of Optometrists in Australia and New Zealand. Nutrients 12:4, pages 1179.
Crossref
Bernard Cuenoud, Isabelle Rochat, Maria Gosoniu, Lenaick Dupuis, Evan Berk, Anke Jaudszus, Jochen Mainz, Gaudenz Hafen, Maurice Beaumont & Cristina Cruz-Hernandez. (2020) Monoacylglycerol Form of Omega-3s Improves Its Bioavailability in Humans Compared to Other Forms. Nutrients 12:4, pages 1014.
Crossref
Alexis Ceecee Zhang, Manikkuwadura Eranda Harshan De Silva, Richard J MacIsaac, Leslie Roberts, Jordan Kamel, Jennifer P Craig, Ljoudmila Busija & Laura E Downie. (2020) Omega-3 polyunsaturated fatty acid oral supplements for improving peripheral nerve health: a systematic review and meta-analysis. Nutrition Reviews 78:4, pages 323-341.
Crossref
Jean-François Lapointe, Laurent Harvey, Sarya Aziz, Robert A. Hegele & Pierre Lemieux. (2019) Evaluation of OM3-PL/FFA Pharmacokinetics After Single and Multiple Oral Doses in Healthy Volunteers. Clinical Therapeutics 41:12, pages 2500-2516.
Crossref
Atsushi Sakamoto, Masao Saotome, Keisuke Iguchi & Yuichiro Maekawa. (2019) Marine-Derived Omega-3 Polyunsaturated Fatty Acids and Heart Failure: Current Understanding for Basic to Clinical Relevance. International Journal of Molecular Sciences 20:16, pages 4025.
Crossref
Ahmed M. Darwesh, Deanna K. Sosnowski, Tim YT. Lee, Hedieh Keshavarz-Bahaghighat & John M. Seubert. (2019) Insights into the cardioprotective properties of n-3 PUFAs against ischemic heart disease via modulation of the innate immune system. Chemico-Biological Interactions 308, pages 20-44.
Crossref
Kevin C. Maki & Mary R. Dicklin. (2019) Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates. Current Opinion in Clinical Nutrition & Metabolic Care 22:2, pages 116-123.
Crossref
Jean-François Lapointe, Laurent Harvey, Sarya Aziz, Heather Jordan, Robert A. Hegele & Pierre Lemieux. (2019) A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States. Clinical Therapeutics 41:3, pages 426-444.
Crossref
Kevin C. Maki, Orsolya M. Palacios, Mary A. Buggia, Rupal Trivedi, Mary R. Dicklin & Cathleen E. Maki. (2018) Effects of a Self–micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State. Clinical Therapeutics 40:12, pages 2065-2076.
Crossref
Akshay Goel, Naga Pothineni, Mayank Singhal, Hakan Paydak, Tom Saldeen & Jawahar Mehta. (2018) Fish, Fish Oils and Cardioprotection: Promise or Fish Tale?. International Journal of Molecular Sciences 19:12, pages 3703.
Crossref
Kevin C Maki. (2018) Long-Chain Omega-3 Fatty Acid Bioavailability: Implications for Understanding the Effects of Supplementation on Heart Disease Risk. The Journal of Nutrition 148:11, pages 1701-1703.
Crossref
Anna Lindblom, Cecilia Ericsson, Therese Hagstedt, Ann Kjellstedt, Jan Oscarsson & Nicholas D. Oakes. (2018) Uptake and tissue accretion of orally administered free carboxylic acid as compared to ethyl ester form of docosahexaenoic acid (DHA) in the rat. PLOS ONE 13:8, pages e0201367.
Crossref
Björn Lindkvist, Catarina Nilsson, Mats Kvarnström & Jan Oscarsson. (2018) Importance of pancreatic exocrine dysfunction in patients with type 2 diabetes: A randomized crossover study. Pancreatology 18:5, pages 550-558.
Crossref
Frédéric Destaillats, Manuel Oliveira, Viktoria Bastic Schmid, Isabelle Masserey-Elmelegy, Francesca Giuffrida, Sagar Thakkar, Lénaïck Dupuis, Maria Gosoniu & Cristina Cruz-Hernandez. (2018) Comparison of the Incorporation of DHA in Circulatory and Neural Tissue When Provided as Triacylglycerol (TAG), Monoacylglycerol (MAG) or Phospholipids (PL) Provides New Insight into Fatty Acid Bioavailability. Nutrients 10:5, pages 620.
Crossref
Lane B. Benes, Nikhil S. Bassi, Mohamad A. Kalot & Michael H. Davidson. (2018) Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia. Cardiology Clinics 36:2, pages 277-285.
Crossref
Wolf-Hagen Schunck, Anne Konkel, Robert Fischer & Karsten-Henrich Weylandt. (2018) Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases. Pharmacology & Therapeutics 183, pages 177-204.
Crossref
Erik S.G. Stroes, Andrey V. Susekov, Tjerk W.A. de Bruin, Mats Kvarnström, Hong Yang & Michael H. Davidson. (2018) Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial. Journal of Clinical Lipidology 12:2, pages 321-330.
Crossref
Yoshinori Noda, Catarina Nilsson, Hitoshi Shimada, Hyosung Kim, Torbjörn Lundström & Toshitaka Yajima. (2018) Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega-3-Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single-Blind, Randomized, Placebo-Controlled Trial. Clinical Pharmacology in Drug Development 7:2, pages 177-187.
Crossref
Gou-Chun Chen, Wen-Hung Chen, Kuo-Tang Tseng & Pei-Min Chao. (2017) The anti-adiposity effect of bitter melon seed oil is solely attributed to its fatty acid components. Lipids in Health and Disease 16:1.
Crossref
Eliot A. Brinton & R. Preston Mason. (2017) Prescription omega-3 fatty acid products containing highly purified eicosapentaenoic acid (EPA). Lipids in Health and Disease 16:1.
Crossref
Elliot Offman, Michael Davidson, Mohammad Abu-Rashid, Peng Chai & Catarina Nilsson. (2017) Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers. European Journal of Drug Metabolism and Pharmacokinetics 42:5, pages 815-825.
Crossref
Roksan Libinaki & Paul Gavin. (2017) Changes in Bioavailability of Omega-3 (DHA) through Alpha-Tocopheryl Phosphate Mixture (TPM) after Oral Administration in Rats. Nutrients 9:9, pages 1042.
Crossref
Elliot Offman, Michael Davidson & Catarina Nilsson. (2017) No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers. American Journal of Cardiovascular Drugs 17:3, pages 251-260.
Crossref
Elliot Offman, Michael Davidson & Catarina Nilsson. (2017) Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers. Journal of Clinical Lipidology 11:3, pages 739-748.
Crossref
David S. Siscovick, Thomas A. Barringer, Amanda M. Fretts, Jason H.Y. Wu, Alice H. Lichtenstein, Rebecca B. Costello, Penny M. Kris-Etherton, Terry A. Jacobson, Mary B. Engler, Heather M. Alger, Lawrence J. Appel & Dariush Mozaffarian. (2017) Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease. Circulation 135:15.
Crossref
Miguel A. Lopez-Toledano, Thorsteinn Thorsteinsson, Ahmed A. Daak, Kevin C. Maki, Colleen Johns, Adrian L. Rabinowicz & Frederick D. Sancilio. (2017) Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3–acid ethyl esters with an Advanced Lipid Technologies TM (ALT ® )–based formulation. Journal of Clinical Lipidology 11:2, pages 394-405.
Crossref
Miguel A. Lopez-Toledano, Thorsteinn Thorsteinsson, Ahmed Daak, Kevin C. Maki, Colleen Johns, Adrian L. Rabinowicz & Frederick D. Sancilio. (2017) A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies TM (ALT ® ) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza ®. Clinical Therapeutics 39:3, pages 581-591.
Crossref
Kevin C. Maki, Colleen Johns, William S. Harris, Mark Puder, Steven D. Freedman, Thorsteinn Thorsteinsson, Ahmed Daak, Adrian L. Rabinowicz & Frederick D. Sancilio. (2017) Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance. Clinical Therapeutics 39:3, pages 652-658.
Crossref
Hitoshi Shimada, Catarina Nilsson, Yoshinori Noda, Hyosung Kim, Torbjörn Lundström & Toshitaka Yajima. (2017) Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial. Journal of Atherosclerosis and Thrombosis 24:9, pages 980-987.
Crossref
Kevin C. Maki, George Bobotas, Mary R. Dicklin, Margie Huebner & William F. Keane. (2017) Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables. Journal of Clinical Lipidology 11:1, pages 102-109.
Crossref
A. Pirillo, G.D. Norata & A.L. Catapano. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III 663 693 .
Jonathan Fialkow. (2016) Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products. American Journal of Cardiovascular Drugs 16:4, pages 229-239.
Crossref
Johanna T Dwyer, Kristin H Rubin, Kevin L Fritsche, Tricia L Psota, DeAnn J Liska, William S Harris, Scott J Montain & Barbara J Lyle. (2016) Creating the Future of Evidence-Based Nutrition Recommendations: Case Studies from Lipid Research. Advances in Nutrition 7:4, pages 747-755.
Crossref
Jyothi Maria Veigas & Gabriel Fernandes. 2016. Omega-3 Fatty Acids. Omega-3 Fatty Acids 585 598 .
Juan Tamargo & María Tamargo. 2016. Omega-3 Fatty Acids. Omega-3 Fatty Acids 541 584 .
Michael A. Leslie, Daniel J. A. Cohen, Danyelle M. Liddle, Lindsay E. Robinson & David W. L. Ma. (2015) A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals. Lipids in Health and Disease 14:1.
Crossref
Richard Kones & Umme Rumana. (2015) Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer Drugs. Drugs 75:11, pages 1201-1228.
Crossref
Penny M Kris-Etherton & Jennifer A Fleming. (2015) Emerging Nutrition Science on Fatty Acids and Cardiovascular Disease: Nutritionists' Perspectives. Advances in Nutrition 6:3, pages 326S-337S.
Crossref
Anne Hedengran, Pal B. Szecsi, Jørn Dyerberg, William S. Harris & Steen Stender. (2014) n-3 PUFA Esterified to Glycerol or as Ethyl Esters Reduce Non-Fasting Plasma Triacylglycerol in Subjects with Hypertriglyceridemia: A Randomized Trial. Lipids 50:2, pages 165-175.
Crossref
Eric J. Brandt & Michael H. Davidson. 2015. Combination Therapy In Dyslipidemia. Combination Therapy In Dyslipidemia 45 64 .
Hannah A. Blair & Sohita Dhillon. (2014) Omega-3 Carboxylic Acids (Epanova®): A Review of Its Use in Patients with Severe Hypertriglyceridemia. American Journal of Cardiovascular Drugs 14:5, pages 393-400.
Crossref
Katie E. Lane, Weili Li, Chris Smith & Emma Derbyshire. (2014) The bioavailability of an omega-3-rich algal oil is improved by nanoemulsion technology using yogurt as a food vehicle. International Journal of Food Science & Technology 49:5, pages 1264-1271.
Crossref
John J.P. Kastelein, Kevin C. Maki, Andrey Susekov, Marat Ezhov, Borge G. Nordestgaard, Ben N. Machielse, Douglas Kling & Michael H. Davidson. (2014) Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial. Journal of Clinical Lipidology 8:1, pages 94-106.
Crossref
Michael H. Davidson. (2013) Omega-3 fatty acids. Current Opinion in Lipidology 24:6, pages 467-474.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.